<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study reports 6 cases of primary follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the testis (PFLT) in children and adolescents correlated with clinical presentation, pathologic features, treatment, and outcome </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 6 patients (age, 3 to 16 y; median, 4 y) had PFLT grade 3 with disease limited to the testis, completely resected and treated with 2 courses of chemotherapy (<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="8382">prednisone</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Event-free survival was 100% (follow-up: median, 73 mo; mean, 53 mo; range, 6 to 96 mo) </plain></SENT>
<SENT sid="3" pm="."><plain>In conclusion, clinical outcome in children and adolescents with PFLT is excellent with treatment including complete surgical resection and 2 courses of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="8382">prednisone</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> </plain></SENT>
</text></document>